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a  b  s  t  r  a  c  t
A  vast  majority  Chinese  herbal  medicines  (CHM)  are  traditionally  administered  as  individually  prepared
water  decoctions  (tang)  which  are  rather  complicated  in  practice  and  their  dry  extracts  show  techno-
logical  problems  that  hamper  straight  production  of  more  convenient  application  forms.  Modernised
extraction  procedures  may  overcome  these  difﬁculties  but  there  is  lack  of  clinical  evidence  supporting
their  therapeutic  equivalence  to  traditional  decoctions  and  their  quality  can  often  not solely  be  attributed
to  the  single  marker  compounds  that  are  usually  used  for chemical  extract  optimisation.  As  demonstrated
by  the  example  of  the rather  simple  traditional  TCM  formula  Danggui  Buxue  Tang, both  the  chemical  com-
position and  the  biological  activity  of  extracts  resulting  from  traditional  water  decoction  are  inﬂuenced
by  details  of  the  extraction  procedure  and  especially  involve  pharmacokinetic  synergism  based  on  co-
extraction.  Hence,  a  more  detailed  knowledge  about  the  traditional  extracts’  chemical  proﬁles  and  their
impact on  biological  activity  is  desirable  in  order  to  allow  the  development  of modernised  extracts  that
factually  contain  the  whole  range  of  compounds  relevant  for the  efﬁcacy  of  the  traditional  application.
We  propose  that these  compounds  can  be identiﬁed  by  metabolomics  based  on comprehensive  ﬁnger-
print  analysis  of  different  extracts  with  known  biological  activity.  TCM  offers  a huge  variety  of  traditional
products  of  the  same  botanical  origin  but with  distinct  therapeutic  properties,  like  differentially  pro-
cessed  drugs  and  special  daodi  qualities.  Through  this  variety,  TCM  gives  an  ideal  ﬁeld  for  the  application
of  metabolomic  techniques  aiming  at the  identiﬁcation  of active  constituents.. Introduction
There is an increasing interest in the use and application of CHM
hroughout the Western hemisphere. Notwithstanding the intake
f powdered herbal drugs in different delivery forms, the typical
reparation of CHM involves some kind of extraction of herbal drug
aterial. Traditionally, the most important delivery form is the
Abbreviations: AR, Astragali Radix; ASR, Angelicae sinensis Radix; CHM, Chi-
ese herbal medicine; CMM,  Chinese Materia Medica; DBT, Danggui Buxue Tang;
P,  ﬁngerprint analysis; PCA, principal component analysis; PLS-DA, partial least
quare discriminant analysis; SCO, supercritical carbon dioxide; SFE, Supercritical
luid Extraction; TCM, traditional Chinese medicine.
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water decoction of a mixture containing typically 2–12 different
herbal materials (Yi and Chang, 2004). It should be explicitly stated
that the item which is ﬁnally administered to a patient is an extract
which is not just represented by the botanical origin of its herbal
ingredients but also inﬂuenced by any procedure that is applied to
the herbal material. Any such procedure may  severely impact upon
the extract’s chemical composition and hence the products’ qual-
ity with regard to its therapeutic efﬁcacy. This is especially true
for complex TCM formulae where we  still lack a comprehensive
understanding of the interactions between the thousands of chem-
ical compounds that constitute the herbal metabolome(s). Besides
showing synergistic effects on a pharmacodynamic level, chem-
Open access under CC BY-NC-ND license.ical compounds of a TCM formula or even an individual herbal
material can also interact with each other (i) on a pharmacoki-
netic level, inﬂuencing the solubility, stability or resorption of
compounds or (ii) on a biochemical level, where residual herbal
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nzymes may  impact the chemical composition; (iii) a mixture of
erbal drugs could even be shown to contain metabolites that none
f the individual herbal ingredients displayed (Nüsslein et al., 2000;
pinella, 2002; Gu et al., 2004; Nualkaew et al., 2004; Ma  et al.,
009; Nahrstedt and Butterweck, 2010). Facing this complexity,
he recent approaches for modernisation of CHM, aiming at the
evelopment of more convenient and better standardised prod-
cts, bear the risk that such features are lost by turning away from
he traditional products and their traditional drug processing and
xtraction procedures. Extract optimisation is frequently guided
y the analysis of single compounds which can often be regarded
s the active substance (Yan et al., 2010). Yet, lacking the appro-
riate knowledge, the activity of many herbal preparations cannot
e clearly linked to single chemical compounds (Vlietinck et al.,
009). Even very well established herbal products like extracts of
alicis cortex have shown efﬁcacy beyond that which is explicable
y their content of salicin derivatives which have been consid-
red to solely constitute the extract’s active substance for decades
Schmid et al., 2001). With regard to CHM, it seems desirable that
he traditional procedures like the unique pàozhì drug processing
nd the extraction of speciﬁc combinations of herbal drugs are sys-
ematically investigated for their impact on the herbal extracts’
herapeutic qualities and metabolomes (Yi and Chang, 2004; Zhao
t al., 2010). In this review we will describe the current situation
nd problems connected to the extraction and compound anal-
sis of CHM and show possible research approaches to gain the
hemical information required for a rational extract modernisation
hat gives consideration to the complex composition of traditional
reparations.
. Traditional extraction of CHM
The majority of CHM for oral use is applied as water decoc-
ions (tang). Other oral preparations include macerates in aqueous
thanol, the intake of powdered drugs suspended in water or pre-
ared in pills, e.g. with honey, water or rice gruel as excipients (Li
t al., 2007; Martin and Stöger, 2008). Decoctions, macerates and
uspensions are very simple to prepare and allow a high ﬂexibility
f the recipes. A factor which fundamentally inﬂuences the chem-
cal composition of extracts is the pàozhì processing of the crude
rug prior to extraction. This is of special importance for the detox-
ﬁcation of toxic materials like Aconitum drugs (Singhuber et al.,
010) but also for the preservation of active constituents, ease of
dministration, ﬂavour correction or cleansing (Zhu, 1998). Many
rugs can be processed by various methods like stir-frying, steam-
ng or calcining in order to gain a product with altered therapeutic
roperties and – implicitly – altered chemical composition (Zhao
t al., 2010; Zhan et al., 2011).
To prepare a typical traditional decoction, a complex TCM for-
ula is macerated with water for a period of time before a ﬁrst
oiling step follows. After ﬁltration, the herbal material is re-
xtracted a second time (usually with less water) and the combined
xtracts are ingested and/or kept for further use. The time spans for
oaking and cooking depend on the drugs as well as on the indica-
ion. As a rule of thumb, decoctions for acute conditions are cooked
or a shorter period of time as compared to preparations for chronic
iseases. Over thousands of years numerous special instructions for
he boiling process have been developed in the use of CHM. These
ethods seem to be related to the different physical, chemical and
harmacological characteristics of the active compounds (Martin
nd Stöger, 2008; Körfers and Sun, 2009).Herbal drugs containing volatile or temperature-sensitive sub-
tances are added only a few minutes before the end of the ﬁrst
oiling period to avoid losses or decomposition (hòuxià). Expen-
ive drugs, e.g. Ginseng Radix or Panacis quinquefolii Radix mightrmacology 140 (2012) 482– 491 483
be cooked separately to optimise the yield and avoid adsorption
of active compounds to other ingredients within the prescription
(lìngjia¯n, lìngdu¯n). In some instances drugs have to be added to the
mixture wrapped in a thin cloth (ba¯ojia¯n), this occurs with drugs
like Typhae Pollen, which might lead to turbid decoctions or Inulae
Flos which contains drug particles which could cause intestinal irri-
tations. For toxic drugs such as Aconiti radix, which are only used
orally after pàozhì processing, additional cooking steps or longer
boiling times for the preparation are recommended. In prepara-
tions containing Acori Rhizoma, an extended decoction process (in
summary 3 h) has been proven to be very efﬁcient for the reduction
of genotoxic ß-asarone (Chen et al., 2009).
3. The example of Danggui Buxue Tang (DBT)
In order to evaluate the signiﬁcance of traditional procedures
for the therapeutic value of a CHM, the rather simple two-herb for-
mula DBT has been chosen as a model to investigate the inﬂuence
of numerous extraction parameters on the chemical composition
and pharmacological efﬁcacies of a water decoction. The traditional
composition of DBT as established over the centuries is reported as
ﬁve parts Astragali Radix (AR) and one part Angelicae sinensis Radix
(ASR). An investigation of several mixtures with different ratios of
the two  drugs has shown the best pharmacological effects as well
as the highest yields of the (active) markers astragaloside IV, caly-
cosin, formononetin, ferulic acid, total saponins, total ﬂavonoids
and total polysaccharides for the traditional composition, while
the undesired compound ligustilide was found to be least con-
centrated with this ratio. The concentrations of these compounds
varied over the examined drug ratios (AR:ASR from 1:1 to 10:1)
by a factor of ∼2, demonstrating a signiﬁcant impact of the drug
ratio on the extraction yield (Dong et al., 2006; Po et al., 2007).
Systematic investigations compared different durations of boiling,
drug-solvent-ratios and numbers of extractions for DBT and also
examined the chemical properties of both herbal ingredients’ indi-
vidual extracts. It could be shown that the treatment with DBT
was  up to twice as effective as individual extracts of its herbal
ingredients at the same concentration. Interestingly, the extraction
corresponding most closely to the traditional prescription (twofold
extraction of the drug mixture with the eightfold amount of water
and an entire boiling time of 2 h) resulted in the best extraction of
active markers and the best effect in two bio-assays (Song et al.,
2004; Gao et al., 2006). A mixture of individually prepared extracts
of AR and ASR showed an inferior pharmacological effect when
compared to the traditional co-extraction of the drugs as well as
a lower concentration of active markers. It is interesting to note
that the investigated markers from ASR (ligustilide and ferulic acid)
showed an astonishing increase of concentration of more than 25
fold when co-extracted with ASR, indicating a massive inﬂuence of
AR on the extraction of these compounds (Mak  et al., 2006). Another
study of DBT yielded similar results with respect to biological activ-
ity, however, the chromatographic ﬁngerprints did not show such
a huge inﬂuence of co-extraction on the ASR markers. The authors
concluded that other, non-observed compounds inﬂuenced by co-
extraction would impact the biological activity (Choi et al., 2011).
The pàozhì processing of ASR with rice wine prior to extraction was
also examined and resulted in higher extraction yields of astraga-
loside IV, isoﬂavones and polysaccharides (Dong et al., 2006). As
the processing of ASR with rice wine results in a decreased con-
centration of ligustilide in the processed product, it was  examined
if the co-extraction of AR with pure ligustilide would impact the
extraction yields of AR markers; in fact, ligustilide lowered the
yields of these markers in a dose-dependent manner, indicating
that the pàozhì processing of ASR inﬂuences the activity of DBT by
altering its properties with regard to co-extraction with AR (Zheng
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t al., 2010). Further, the exchange of ASR with another drug, Radix
huanxiong, which shares the occurrence of ligustilide and ferulic
cid with ASR, was examined, resulting in both an inferior pharma-
ological efﬁcacy and lower concentrations of the AR markers when
ompared to a DBT extract, indicating that other, non-observed
ompounds of ASR may  impact the quality of DBT (Li et al., 2009).
It must be stated that the activities in the above mentioned stud-
es were assessed by completely different methods. Nevertheless,
he example of DBT impressively demonstrates that the subject of
xtraction is not a trivial one and that the chemical composition
nd pharmacological efﬁcacies of the traditional water decoctions
re inﬂuenced to an astonishing degree by a multitude of factors
hich apparently have found their optimum in the traditional DBT
rescription.
. Modernisation of CHM extracts
The development of modernised extracts and application forms
s desired for numerous reasons: (i) individually prepared water
ecoctions are more likely to entail quality shortcomings caused
y improper herbal drugs when compared to herbal medicines
roduced in industrial scale under best controllable conditions.
ii) Water decoctions are probably the worst possible preparation
n terms of stability and may  give rise to microbial contamina-
ions, decomposition of constituents by hydrolytic or oxidative
eactions or precipitations that may  impact the product’s qual-
ty. (iii) TCM water decoctions are infamous for their unpleasant
rganoleptic properties. (iv) The rather complicated and time con-
uming preparation and storage of water decoctions may  cause
ompliance problems while modernised application forms based
n dry extracts (granules, capsules, tablets, etc.) are easily man-
geable for both patients and practitioners. (v) The possibility
or standardisation of large-scale extracts is a prerequisite for
uture evidence-based research. (vi) The blinding of clinical studies
mploying traditional water extracts is hampered by their strong
rganoleptic properties (Martin and Stöger, 2008; Flower et al.,
011).
As evident from the studies on DBT, turning away from
raditional procedures bears the risk of altering the product’s
herapeutic properties. Therefore some modernisation approaches,
irectly based on water decoctions, have been developed to over-
ome the above mentioned problems. One such approach involves
he delivery of water decoctions in sealed, separately packaged,
aily dosages thus increasing the compliance and stability of the
roduct. Also an unpleasantly tasting herbal placebo composed of
ine culinary herbs was designed (Flower et al., 2011).
.1. Pressurised hot water
Pressurised hot water extraction at high temperature is some-
imes applied and can be regarded as a kind of modernisation. This
ethod has been shown to decrease the extractant’s polarity and
hus provides the extraction of a wider range of compounds (Deng
t al., 2007). Nevertheless, it is reported that the use of pressure
ookers for the preparation of decoctions to shorten cooking times
eads to less active preparations (Martin and Stöger, 2008).
.2. Formation of granules
A major approach to modernise and facilitate the application
f CHM was the introduction of granules, which are usually pre-
ared from decoctions by ﬂuid-bed granulation or spray-drying.
s the technological properties of such extracts are impaired by
igh amounts of hydrophilic constituents, especially carbohydrates
hich result in hydroscopic, sticky and hence hardly processable
xtracts. Thus, excipients are added to the decoction of the herbalrmacology 140 (2012) 482– 491
material (one step procedure) or mixed with the spray-dried prod-
uct (two step procedure) (Martin and Stöger, 2008; Ai et al., 2008).
Rather high amounts of additives are required (Wang et al., 2011)
and these additives further add on to the extract dose which is
already quite large due to the presence of polar “bulk material”.
Another method to improve the technological properties is the
removal of highly polar compounds from the extract by ethanol
precipitation prior to drying (Tan et al., 2006). Such preparations
can be instantly applied by suspension in hot water or can be used
to produce single dosage forms like capsules. An advantage is that
these products can be applied quickly avoiding the time consuming
preparation of a decoction.
4.3. Use of less polar extractants
Other modernisation approaches employ less polar extractants
and hence can yield a dry extract with superior technologi-
cal properties when compared to dried water extracts. These
approaches comprise the extraction with (hydro)alcoholic or
organic extractants performed by different extraction techniques
like maceration, Soxhlet extraction, microwave-assisted extrac-
tion, ultrasonic extraction or accelerated solvent extraction.
Though these different extraction techniques show clear distinct
properties (e.g. thermal decomposition during Soxhlet extraction,
solvent limitations for microwave-assisted extraction), the dif-
ferences can mainly be attributed to extraction speed while the
chemical composition of the resulting extracts after establishment
of equilibration is mainly inﬂuenced by the kind of extractant
used and its temperature (Yan et al., 2010). From a general view,
the differences in extract composition between these techniques
can be regarded as negligible when compared to the differences
between any of these techniques employing (hydro)alcoholic or
organic solvents and a traditional water decoction. A study com-
paring hydroalcoholic extracts of more than 30 drugs with their
respective water decoctions clearly showed that decoction in most
cases allows an extraction of phenolics which is similarly efﬁcient
as maceration with 50% ethanol. The yields after extraction with
80% methanol, a very common method for analytical determina-
tion of phenolics and their testing on antioxidant activity, was
much lower. In this study, most of the decoctions, among them
drugs from Rehmannia glutinosa Libosch, Astragalus membranaceus
(Fisch.) Bge. or Atractylodes macrocephala Koidz., showed better
or similar antioxidant activity as compared to the hydroethanolic
macerates. The activity of the 80% methanolic extracts was  worse
for almost all tested drugs (Li et al., 2007). In a comparison of aque-
ous and ethanolic extracts from different drugs a more pronounced
effect on various CYP enzymes was  proven for the water extracts
(Tang et al., 2006).
4.4. Supercritical Fluid Extraction (SFE)
A completely different extraction technique that by its techni-
cal properties is attractive for large scale extraction, is Supercritical
Fluid Extraction (SFE). This is an extraction technique which takes
advantage of the enhanced solvating and penetrating capacity of
gases or liquids in their critical phases (ASTM, 2006). The unique
properties of supercritical ﬂuids were observed more than a cen-
tury ago, but only in the last four decades SFE has emerged as an
extraction technique (Khosravi-Darani, 2010). Advantages of SFE
in contrast to conventional extraction are (i) superior extraction
efﬁciency and selectivity for low polar phytochemicals. The extrac-
tion efﬁciency and selectivity can be tuned by optimising pressure
and temperature (Wang et al., 2008; Liu et al., 2008a). (ii) Among
the many applicable solvents for SFE, the most commonly used
for extraction of CHM is supercritical carbon dioxide (SCO) which
is inert, easily available, inexpensive, odourless, environmental
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a complete qualitative and quantitative assessment of a biological
sample’s whole chemical composition.
1 The literature research was  performed with either Scopus or Pubmed using
an OR-conjuncted combination of any botanical identiﬁers given by the consor-
tium’s priority list of species (CP2005 Latin binominal species name, taxonomically
accepted Latin binominal species name, Latin drug names, Pinyin names, LatinH. Sheridan et al. / Journal of Eth
riendly and has mild critical point properties. To increase the sol-
bility of compounds from CHM in SCO, small amounts of polar
odiﬁers, e.g. ethanol, may  be added, usually not more than 10% of
he amount required for conventional extraction techniques (Chen
nd Ling, 2000; Silva et al., 2009; Chen et al., 2011). (iii) SCO is eas-
ly removable from the extract by depressurization, and thus no
olvent residue is left in the extract (Vagi et al., 2002). (iv) Prefer-
ble product stability. The extraction is conducted at oxygen and
ight free operating conditions which prevent oxidation and light
ependent changes, for example, a SCO extract of tomatoes could
e stored for more than half a year at −20 ◦C without lycopene loss
Lenucci et al., 2010). Furthermore, the low temperatures minimize
hermal degradation of sensitive materials, e.g. volatiles. As a green
eparation technique, SFE has a promising future in its application
n the ﬁelds of TCM and natural products (Martinez, 2008).
However, there are limitations for any of the extraction method-
logies to be considered for the production of more convenient
pplication forms. Because of the “Lipinski rule of ﬁve” (Lipinski
t al., 2001), it is generally believed that less polar extractants like
lcohols, acetone or SCO are capable of extracting pharmacologi-
ally relevant analytes while excluding higher amounts of polar,
echnologically difﬁcult “bulk material” like carbohydrates, pro-
eins, amino acids etc. from the extract. However, this is a very
eductionistic view which actually applies to a single active com-
ound and especially excludes the possibility of pharmacokinetic
ynergism in herbal extracts, which has been shown to have a
ajor impact on the chemical composition of CHM (e.g. Mak  et al.,
006). It cannot be generally ruled out that the extraction of very
olar constituents (needing water as extractant) can be essential for
roducing efﬁcient extracts from speciﬁc drugs or for speciﬁc appli-
ations, polymeric carbohydrates or compatible solutes like ectoine
re examples for such highly polar bioactive compounds (Lentzen
nd Schwarz, 2006). When relating any modernised CHM extract to
he long experience of TCM it should be considered that its clinical
fﬁcacy should at least match the one of the traditional prepara-
ion it relates to. It has been shown that the single active markers
hat are typically used for the quality control of herbal drugs may
ot be able to fully explain a product’s quality, especially when
he drug is used as part of a co-extracted herbal mixture (Schmid
t al., 2001; Li et al., 2009; Vlietinck et al., 2009), and frequently
ot even an active marker is known but analytical markers without
nown clinical relevance are used as a surrogate. As a consequence,
uch single markers cannot be generally recommended to guide the
ptimisation of an extract. Hence, for the rational development of
ew products it is essential to increase our knowledge about which
hemical compounds deﬁne the quality of a traditional prepara-
ion, so a production chain can be established that ﬁnally yields an
mproved product lacking technologically problematic “bulk mate-
ial” while conserving any compound that has been shown to be
elevant for the traditional product’s quality in terms of clinical
fﬁcacy. In summary, the rational modernisation of CHM requires
urther research to identify chemical compound that can be linked
o an herbal preparation’s quality considering pharmacodynami-
ally and pharmacokinetically relevant compounds.
. Fingerprint analysis in activity studies of herbal extracts
A major challenge in the modernisation of CHM is the incorpo-
ation of between one and twelve herbs in a given formula, thus
onferring a high degree of complexity and the potential for vari-
tion in composition and quality of a preparation. It has also been
stablished that interactions between chemical components may
ake place during traditional co-extraction of complex herbal mix-
ures and thus impact the extract’s chemical composition. Due
o the lack of knowledge about the chemical compounds thatrmacology 140 (2012) 482– 491 485
completely constitute the quality of many CHM, the widespread
practice of using single herb monographs and analysing of sin-
gle compounds for the characterisation of CHM extracts tested in
pharmacological or clinical studies seems to be insufﬁcient. This
is of particular issue when dealing with HM that contain multi-
ple herbs, and can be illustrated by the fact that sometimes the
same, rather unspeciﬁc metabolites are used for the quality assess-
ment of herbal drugs with distinct clinical properties. Examples are
chlorogenic acid, which is used as a marker compound for Caulis
Lonicera, Flos Lonicera and Flos Chrysantemi, or berberine, which is
used as a marker compound for Rhizoma Coptidis and Cortex Phel-
lodendri (Zhou et al., 2008). Consequently, a more comprehensive
view on the chemistry of extracts is desirable. It is obvious that the
metabolomic techniques currently available for ﬁngerprint analy-
sis (FP) of complex biological and herbal samples and those with
evolving applications in this area, have the potential to enhance the
quality control of CHM and to assist with the correlation of bioactiv-
ity with composition. FP can be deﬁned in this context as an analysis
aiming at the representation of an extract’s chemical composition
to a maximum possible degree; while being largely untargeted, FP
can also be used for or as an addition to the quantiﬁcation of single
compounds.
Chromatographic FP and the simultaneous determination of
multiple compounds is becoming an important trend (Liang et al.,
2010). However an analysis of 97 original papers1 assessing bio-
logical effects of CHM extracts revealed that only 16 provided –
exclusively chromatographic – FP data while 24 characterised the
extracts by quantifying relevant single compounds and 57 did not
chemically characterise the tested extract at all. We  consider the
presentation of FP data within activity studies of herbal extracts as
fundamental information for chemical characterisation. Consider-
ing the possible variability of an extract’s chemical proﬁle that can
be caused by differences in the herbal materials (growth conditions,
post-harvest treatment, pàozhì processing, etc.) or manufacturing
(extraction conditions, drying, etc.) it must be stated that the exam-
ined item in such studies is literally unknown without at least some
basic chemical characterisation.
Different methods are used for FP which may  be roughly cat-
egorised as (i) low resolution techniques like TLC or IR-based
methods which are typically applied for assessing the identity or
origin of an herbal material by visual or – in case of NIR – computer
aided comparison of signal patterns, mostly without (detailed)
assignment of signals to chemical compounds (Xie et al., 2006; Sun
et al., 2010). (ii) High resolution techniques like GC, HPLC, MS,  NMR
or hyphenated techniques allow for a detailed assignment of signals
to the detected chemical compounds and are commonly accepted
as well suited for FP aiming at a comprehensive extract charac-
terisation as well as for metabolomic approaches. The advantages
and disadvantages of these methods with regard to suitable tar-
get metabolites, reproducibility of signal intensities and positions,
sensitivity, resolution and sample preparation efforts have been
extensively discussed (Verpoorte et al., 2008). It must be stated that
no available analytical method is capable of fulﬁling the demand forbinominal synonyms). The search result was  then reﬁned by limiting the hits to the
topics “Extraction” and “Chemistry” or adding these terms to the general search term
with “AND” conjunctions for Pubmed, respectively. The 97 papers mentioned here
were chosen from the results by the fact that they assessed the biological activity of
an  herbal extract.
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In order to ﬁnd a recommendable procedure for FP based on cur-
ent practice we analysed 157 original papers2 for the methodology
sed for the general analysis of herbal extracts from Chinese drugs
nd found that a majority of 64% used HPLC-based techniques,
8% used other separation techniques and 18% used spectroscopic
echniques. Restricted to studies involving the assessment of an
xtract’s biological activity, the proportion of HPLC-based tech-
iques raises to 94%, indicating a preference of HPLC for studies
here FP would be advisable. With regard to its analytical proper-
ies and its wide availability, HPLC seems to be an ideal standard
ethodology for FP of many herbal extracts, if some aspects are
onsidered. (i) A precise reproduction of even relative retention
ehaviour is not expectable to a degree that would justify recom-
ending a speciﬁc global method for, e.g. direct data comparison
etween different labs or building up a public FP database. Fur-
hermore, the separation requirements are usually variable for
ifferent extracts and research focuses. (ii) To guarantee a funda-
ental comparability and reproducibility of FP, we recommend the
se of conventional equipment whenever possible, e.g. a most con-
entional RP-18 column based on type-B silica that allows for an
nproblematic separation of basic compounds. Full binary gradient
lution using water and acetonitrile each with 0.1% formic acid will
isplay a maximum possible range of compounds, is LC–MS-ready
nd can be adapted to speciﬁc separation problems by ﬂattening
he gradient slope or including isocratic steps for regions of spe-
ial interest, e.g. for the quantiﬁcation of known active markers. As
ost HPLC systems are not capable of actively cooling the column
ompartment, it is recommended to consider a column tempera-
ure that is higher than usual room temperatures, e.g. 40 ◦C. (iv)
acing the difﬁculties with the exact reproducibility of separation
onditions, it is of importance to offer some orientation within a
resented FP chromatogram. Fundamentally, this can be achieved
y presenting a couple of UV–chromatograms of the examined
xtract recorded at different wavelengths (230 nm,  254 nm,  280 nm
nd 340 nm are suitable for many plant secondary metabolites);
he ratios of a peak’s signal intensities at different wavelengths
an be used as simple qualiﬁers and can be read out from the
resented chromatogram at least for major compounds. UV chro-
atograms can also provide rather reliable relative quantitative
nformation when compared to, e.g. MS-based TICs, though a TIC
r an ELSD chromatogram complements an UV-chromatographic
P with regard to compounds lacking a chromophore. Assignment
f unidentiﬁed peaks to their UV-spectra and/or MS-spectra or
he presentation of 2D contour plots may  give further orientation.
henever possible, chromatographic peaks should be assigned to
ompounds that could be unambiguously identiﬁed.
The presentation of such a FP consisting of several chro-
atograms allows the assessment and basic comparison of extract
haracteristics beyond the quantities of a few markers by number,
osition and characteristics of unidentiﬁed peaks and their peak-
o-peak ratios (Liang et al., 2010). For example, we  could compare
uantitative data of one paper about DBT (Mak  et al., 2006) with
nother paper that did no quantiﬁcation but presented a suitable
P (Choi et al., 2011).
However, there are clear limitations: (i) difﬁcult analytes like
xtremely lipophobic or lipophilic substances, polymers or com-
lex compounds like tannins will not be well assessable by such
 system (ii) the chromatographic selectivity and hence the rel-
tive position or even succession of peaks may  be inﬂuenced by,
.g. the brand and age of the applied column, temperature, gradi-
nt slope or the instrument’s dwell volume. (iii) When comparing
2 Same literature research as indicated above. The 157 papers mentioned here
ere selected because they documented the chemical characterisation of an herbal
xtract.rmacology 140 (2012) 482– 491
peak intensities within a chromatogram or between different chro-
matograms care must be taken, e.g. the signal intensities in any
MS-based chromatogram are strongly biased by complex and
partly instrument-speciﬁc parameters settings, unattended con-
tamination or aging of instrumental components and other factors
which are hardly controllable or reproducible; furthermore, sig-
nal intensities may  be biased by any detector’s linear range. These
limitations could be overcome by the additional presentation of an
1H NMR  spectrum-as NMR  is a method solely based on physical
characteristics with rather limited experimental factors inﬂuenc-
ing signal positions and intensities, the reproducibility is excellent
and hence such data are well suited for the desired establishment
of a public database of FP data, taken that a standardised protocol
can be agreed on. Limitations of 1H NMR  ﬁngerprinting are a rather
low sensitivity and the representation of chemical compounds as
rather complex signal groups which hamper a direct perception
of single chemical entities when compared to well separated chro-
matographic peaks (Verpoorte et al., 2007). Because of the excellent
reproducibility, the increasing use of NMR  for metabolomic studies
and the efforts towards an establishment of public data platforms
make NMR  a feasible alternative also for the FP of extracts in activity
studies.
6. NMR  for ﬁngerprinting and metabolomics
In the last decade the power of 1H NMR  spectroscopy for high
throughput metabolomic analysis of complex mixtures including
plant extracts and traditional medicines has been well established
(Lindon et al., 2000, 2001; Feng and Zhao, 2009; Lao et al., 2009;
Agnolet et al., 2010; Gilard et al., 2010; Novoa-Carballal et al., 2011).
1H NMR  analysis has been used for quality control (Tarachiwin
et al., 2008; Lee et al., 2009; Frédérich et al., 2011), identiﬁca-
tion of compounds, impurities and adulterants (Peng et al., 2004;
Balayssac et al., 2009a,b; Holzgrabe and Malet-Martino, 2011),
quantiﬁcation (Pauli et al., 2005), determination of species ori-
gin (Kang et al., 2008) and correlation of a plant’s metabolome
with biological activity (Tarrago et al., 2006; Kim et al., 2011).
Hyphenated techniques such as LC–NMR have found application
in the analysis of plant extracts, wherein metabolites are separated
and enter the NMR  instrument directly from the HPLC column so
that no isolation and sample manipulation is required (Wolfender
et al., 2001). In metabolomic analysis 1H NMR  has the advantage of
having simple sample preparation, being fast, non-selective and a
non-destructive technique, providing global information in a sin-
gle analysis but also can allow structural characterisation (Gilard
et al., 2010). New advances in instrumentation such as use of
cryogenic probes (Kovacs et al., 2005; Kang et al., 2008), capillary
probes (Hu et al., 2008) and preampliﬁer components (Huan et al.,
2010) together with the use of one and two dimensional strategies
enable the identiﬁcation and quantiﬁcation of multiple samples at
molar concentrations in far shorter times (>15 min) (Lewis et al.,
2007). However, despite these advances one main drawback with
NMR  is the limit of sensitivity when compared to techniques such
as mass spectrometry (10−9 and 10−11 mol  in comparison with
10−19) (Pan and Raftery, 2007). One and two  dimensional 1H NMR
spectra of mixtures and extracts can be very complex making
normal methods of analysis, such as peak resonance assignment
and peak integration very difﬁcult. However, comprehensive and
representative metabolite proﬁles or ﬁngerprints can be gener-
ated (Malet-Martino and Holzgrabe, 2011). The main problems
arise from peak overlap which does not interfere with repro-
ducibility (Dumas et al., 2006) but it does with quantiﬁcation.
Such complex samples generate an enormous amount of data that
needs to be reﬁned to make it amenable to statistical analysis
(Lewis et al., 2007). The combination of 1H NMR  and multivariate
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nalysis is quite often used in metabolomics. Numerous resources
re available to assist with principal component analysis, group
lustering and pattern recognition based on spectral differences
Malet-Martino and Holzgrabe, 2011). These forms of analysis gen-
rate ﬁngerprints that can be used to distinguish between classes
f compound and subsequently different metabolites (Frédérich
t al., 2011). PCA also facilitates the analysis of sample composition,
etermination of sample origin, and can be used for quality control
s demonstrated in a study of Panex ginseng (Yang et al., 2006), and
ecently in Verbascum species when the 1H NMR  datasets gener-
ted for ﬁve species were subjected to PCA and hierarchical cluster
nalysis showing qualitative and quantitative differences between
pecies (Georgiev et al., 2011).
Several new NMR  techniques have been applied to the analy-
is of complex mixtures including Diffusion Ordered Spectroscopy
DOSY), a 1H NMR  method which can be regarded as a “virtual chro-
atography” allowing for the separation of small molecules from
arger ones. It has been applied to the screening of herbal medicines
Peng et al., 2004; Balayssac et al., 2009a,b; Novoa-Carballal et al.,
011). In a recent DOSY NMR  study, Kang et al. (2008) successfully
ifferentiated between the origin and age of Korean and Chinese
anex samples using a cryogenic probe and PCA analysis. The cryo-
enic probe reduced acquisition times to circa 1 min.
In addition the statistical total correlation spectroscopy
STOCSY) method (Sands et al., 2011) is a well-established NMR
pproach to enhancing information recovery from a complex mix-
ure and a valuable method in the elucidation of both inter- and
ntra-metabolite correlations in NMR  metabolomic data sets. A
odiﬁed cryogenic probe ‘on ﬂow’ LC–NMR approach using a
TOCSY variation was used by Cloarec et al. (2007).  Cryoﬂow tech-
ology enables sensitive and efﬁcient NMR  detection of metabolites
n ﬂow. This approach, although applied to drug metabolites in
rine in this study, has wider potential in metabolomics analysis
Cloarec et al., 2007).
The ability of NMR  metabolomic proﬁling to predict biological
ctivity is an important development that may  contribute sig-
iﬁcantly to the correlation between composition of traditional
edicines and their activity. 19F NMR  was used by Tarrago et al.
2006), to identify traditional Chinese medicines possessing pro-
yl oligopeptidase inhibitory activity. Frutos et al. (2006) have also
sed 19F NMR  for the evaluation of the inhibitory activity of new
ompounds against HIV-1 protease. More recently, analysis of 1H
MR  data sets by PCA and partial least square discriminant analy-
is (PLS-DA) have shown clear correlations between the free radical
cavenging activity of Psidium guajava L. (Kim et al., 2011) and the
nxiolytic and sedative activity of Galphimia glauca Cav. with their
espective metabolomes (Cardoso-Taketa et al., 2008).
The increasing number of research publications, detailing the
umerous and varied applications of NMR  in the metabolomic
nalysis of plant extracts and traditional medicines, support the
mportant and evolving role of NMR  as a complementary or stand-
lone technique in the analysis of herbal extracts. Hence the
pplication of NMR  seems also reasonable for FP in activity studies
f CHM. A protocol for NMR-based metabolomic analysis of plant
aterials has been published (Kim et al., 2010) and could generally
e recommended for extract characterisation as well. However, a
ifference has to be considered: While plant metabolomics typ-
cally looks at plant metabolomes and hence tries to avoid the
eneration of artefacts during sample preparation, an activity study
f CHM should look at the “extract metabolome”, namely at the
hemical composition of the very same item that was also used for
ctivity assessment including any possible artefacts and decompo-
ition products that may  result from post-harvest treatment, pàozhì
rocessing or the extraction process and that may  contribute to an
xtract’s efﬁcacy (Xie et al., 2009). A general consideration of any
ind of FP of an herbal extract is that the composition of the samplermacology 140 (2012) 482– 491 487
for FP should be exactly identical to the composition of the sam-
ple that was  used for activity assessment. This means that sample
discrimination, e.g. by incomplete dissolution, different methods
of ﬁltration etc. should be avoided; for example, if a sample for
bioactivity assessment is dissolved in water with a minor amount
of DMSO, the same solution (or even better the very same solution)
should also be used for analysis; if a ﬁltration step is found to be nec-
essary before analysis, the sample for activity assessment should be
subjected to the same ﬁltration procedure. However, this approach
may  be impeded by the different technical requirements of the bio-
logical assays and FP techniques to be used so that compromising
may  become inevitable.
7. Metabolomic approaches for extract optimisation
On its way from the plant to a Chinese Materia Medica (CMM), a
herbal material has to undergo numerous and partly TCM-speciﬁc
production steps that can include storing, washing, rinsing, dry-
ing, remoistening and cutting and eventually the unique pàozhì
processing techniques. All these steps should guarantee that a
preparation made of such a CMM  can develop its full range of
effects and avoid unwanted side effects. Each of these manipula-
tions represents a step in the production chain that can be expected
to inﬂuence the drug’s chemical proﬁle. For example, the drying
of herbal material results in a disorganization of cellular compart-
mentalisation and an oxidative burst both of which are capable to
change plant secondary metabolites by oxidation (e.g. the genera-
tion of sennosides in leaves of Cassia angustifolia Vahl or generation
of primary amide glucosides in Prunus laurocerasus L.) or direct
enzymatic activity (e.g. the generation of secondary glycosides in
Digitalis purpurea L.) until further loss of water stabilises the mate-
rial (Lemli and Cuveele, 1978; Sendker and Nahrstedt, 2009). A very
interesting aspect can be found with regard to pàozhì processing:
there are several examples where the same raw drug material is
processed by different methods to yield products that are claimed
to have improved pharmacological and/or toxicological proper-
ties. Examples for this are Coptidis Rhizoma, Angelicae sinensis
Radix and Aconiti lateralis Radix (Stöger, 1999; Zhao et al., 2010).
Another aspect that is claimed to impact an herbal drug’s thera-
peutical properties is the occurrence of presumably superior daodi
qualities which is attributed to herbs grown in a speciﬁc region.
Taken these claims for granted, the huge variety of CHM should
give an ideal sample set to link these different pharmacological
or toxicological properties to differences in the products’ chemical
proﬁles by metabolomics. A major challenge is that Chinese herbal
medicines are usually administered as a mixture of several herbal
drugs, whereupon the mixture may  show synergetic effects that at
least partly can rely on co-extraction of highly speciﬁc herbal mate-
rials. Even the generation of new metabolites during co-extraction
cannot be ruled out (Mak  et al., 2006; Zheng et al., 2010). This means
that the adulterated properties of, e.g. a pàozhì product could not
become visible before the processed product is co-extracted as part
of an herbal mixture following a traditional protocol.
It is desirable, also from a regulatory point of view, that the above
mentioned impacts on the herbal metabolomes are well charac-
terised and that the state of an herbal drug material within the
production chain can be traced by suitable analytical methods. For
example, the pàozhì processing of TCM drugs is currently controlled
by experienced, long studied masters called Yi Shi,  but without
objective endpoint deﬁnitions (Zhu and Woerdenbag, 1995; Zhao
et al., 2010). A processing method’s chemical impact on the prod-
uct can be assessed by FP of a variety of processed and unprocessed
samples and their subsequent analysis by multivariate statistics
may  lead to the identiﬁcation of speciﬁc markers that could aid
suitable objective endpoints deﬁnitions. The same applies for any
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ther step within the production chain. However, a prerequisite
s that the extracts of (intermediate) products that are to be ana-
ysed are well documented with regard to the production steps they
ad been subjected to. Bioactive compounds may  be identiﬁed if
t is possible to achieve or generate extracts of different materials
rom the same plant species that are highly variable in bioactivity. A
CA may  then discriminate the chemical ﬁngerprints in a way that
eparates the extracts, e.g. by activity or by spatial origin and rele-
ant chemical compounds can subsequently be deduced from their
ontribution to the respective discrimination (Tanaka et al., 2008;
kada et al., 2010). Yet, prominent chemical differences must not
ecessarily be linked to activity. Supervised methods like PLS-DA
ay  overcome this problem by relating chemical ﬁngerprints to a
ependent variable, e.g. the results of a bioactivity assay. Examples
or this procedure have been published for anxiolytic and seda-
ive activity of Galphimia glauca (Cardoso-Taketa et al., 2008) and
ntioxidant activity of Psidium guajaval (Kim et al., 2011).
However, there are limitations to this approach: (i) As multivari-
te statistics cannot distinguish between correlation and causality,
he result must be regarded as a hypothesis and the factual mean-
ng of any identiﬁed compounds or sets of compounds should be
ubjected to further examinations in order to prove the hypothe-
is. (ii) The results of any approach that is supervised by bioactivity
ata can only be as meaningful as the biological test system.
. New emerging technologies for the puriﬁcation of active
ompounds
Once active or synergistically relevant components have been
dentiﬁed using the metabolomic methods described above, it will
till be a challenge to isolate sufﬁcient material for identiﬁcation,
oxicology studies and combining with other identiﬁed actives to
odel potentially simpliﬁed Chinese medicines that still include
ny component relevant to their traditional efﬁcacy. The isolation
f pure compounds has always been difﬁcult as any natural product
nd especially complex products as CHM are complicated systems
onstituted of hundreds and thousands of chemical entities, often
ith unknown structures and low abundances. Modern HPLC based
echnologies allow for a high level of automation and hence a high
hroughput also for the preparative separation, concentration, dry-
ng and weighing of natural product fractions and pure compounds
n a scale that is sufﬁcient for building natural product libraries
Abel et al., 2002; Eldrige et al., 2002; Koehn, 2008). Also orthogonal,
wo-dimensional separation systems employing novel stationary
hases with distinct chromatographic selectivity have been used
or the isolation of active constituents from natural products (Liu
t al., 2008b, 2010; Guo et al., 2009). However, as the loading
apacity for well resolved preparative HPLC is suitable for structure
lucidation by NMR  (e.g. Glauser et al., 2008) and high-throughput-
creening (Tu et al., 2010), the amounts needed for experimental
ork verifying the results of a metabolomic approach may  exceed
he amounts that can be reasonably achieved by HPLC.
One emerging new technology with high loading capacity that
as been extensively used in China for the isolation and identiﬁca-
ion of new active ingredients is counter-current chromatography
Chen et al., 2007; Sutherland and Fisher, 2009; Zhang et al.,
009; Qi et al., 2010; Zhang et al., 2010). This is an entirely liq-
id ﬂow process with immiscible liquid mobile and stationary
hases where compounds are separated on their differential sol-
bility in these two liquids. This technology was introduced in
966 by Ito who invented the coil planet centrifuge to demonstrate
ow compounds could be separated by the counter-current motion
f two immiscible liquids in a coil/column undergoing a variable
orce ﬁeld (Ito et al., 1966). This became known as counter-current
hromatography (CCC), a continuous form of Craig’s counter-
urrent distribution (Craig and Post, 1949). CCC with a coil planetrmacology 140 (2012) 482– 491
centrifuge is a hydrodynamic process, where, if the ﬂow stops the
two phases move to opposite ends of the column. Later hydrostatic
process known as centrifugal partition chromatography was devel-
oped. Hydrodynamic CCC occurs in a long continuous tube that has
been wound to form a coil (Ito, 2005). In chromatographic terms
this coil is the column, which is rotated in a planetary (epi-cyclic)
motion retaining one solvent phase (stationary) while allowing
another solvent phase to be pumped through the column. Within
the column there are numerous alternating zones where the sol-
vent phases are mixed together and then settled into separate
layers. These alternating zones are the extraction stages and there
are many within the column. Today, there can be found high-speed
CCC (HSCCC) and high-performance CCC (HPCCC) (Sutherland et al.,
2011). The difference is the separation efﬁciency of the equipment
used (HPCCC works at higher g-level or force ﬁeld) and has the abil-
ity to purify products more rapidly with a higher throughput and
without loosing purity.
The second form, hydrostatic CCC is commonly known as cen-
trifugal partition chromatography (CPC) which is a separation
technique made up of a series of interlinked cells located around
a rotor – each cell being an extraction stage (Foucault, 1994). One
phase is held in the cell (stationary) while the mobile phase ﬂows
through allowing extraction to occur between the phases. CPC
instruments have only one rotational axis and therefore, centrifu-
gal force ﬁeld is uniform and if the ﬂow stops the stationary phase
does not redistribute hence its hydrostatic notation. Historically,
HSCCC and HPCCC are more widespread within China than CPC.
The CCC/CPC process is more like a continuous liquid–liquid
extraction process than a chromatography one, which makes it very
attractive for Chinese herbs as there is no loss of sample ingredients
and the process is scalable (Sutherland et al., 2011). Extracts can be
dissolved in either phase and injected into the column with the
mobile phase – compounds elute from the column at various times
according to their afﬁnity to the stationary phase. This new technol-
ogy has proved itself very useful for ﬁngerprinting also (Zhang et al.,
2010). The big advantage is that it can focus on a particular com-
pound and even concentrate it in the column using an intermittent
continuous counter-current extraction mode where hydrophobic
impurities elute from one end of the column and hydrophilic ones
from the other while the target compound itself is being concen-
trated in the column (Hewitson et al., 2009).
9. Summary and conclusions
Chinese herbal medicines have been used for the treatment of
numerous ailments for millennia and their use is gaining increasing
popularity across the northern hemisphere. However, the tradi-
tional water decoction is a disadvantageous formulation especially
for reasons of stability and compliance; furthermore the highly
polar extracts obtained from these decoctions bear technological
difﬁculties that hamper the development of modernised applica-
tion forms. The move toward the use of less polar solvent extracts
of herbs, rather than decoctions may  overcome these problems
but may  also cause complications by distorting the composition
and activity of CHM’s prepared in this fashion when compared
with traditional decoctions. It has also been established that inter-
actions between chemical components may  take place during
traditional co-extraction of complex herbal mixtures and thus
impact the extract’s chemical composition. The move towards new
formulations including the use of Granules represents a signiﬁcant
modernisation. However these preparations, with the inclusion of
large quantities of excipients, deviate signiﬁcantly from the tradi-
tional decoctions used in CHM. The use of such modern dispensing
systems also opens up the legal status of these formulations when
being viewed by legislators.
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It is obvious that the techniques currently being used for the
etabolic ﬁngerprinting of complex biological and herbal samples
ave the potential to help enhancing the quality, safety and efﬁ-
acy of CHM by providing a comprehensive view on a multitude
f quality-determining compounds. However, we  believe that we
re not yet at a point where modern metabolic ﬁngerprinting can
ully unfold this potential. This is because of the special features
nd complex issues that obviously exist especially with the use of
omplex herbal medicines and that have to date impeded a compre-
ensive knowledge about their quality determining components.
urrently, we still rely on monographs for single herbs with their
ssociated chemical markers when the quality analysis is actually
eing carried out on a multicomponent medicine.
But then it is this variety of chemical and also therapeutic
roperties that makes an essential prerequisite for the success-
ul identiﬁcation of active components and analytical markers by
etabolomics, so that the same complexity that often hampers an
nderstanding of CHM by reductionist means may  turn out to be the
ey for a successful metabolomic approach. Researching and under-
tanding this variation is a huge task, especially when considering
hat both chemical and therapeutic properties of a speciﬁc drug and
ts constituents may  only become visible after co-extraction within
 complex TCM formula. The ability to assess information relating
o FP and activity testing between different research groups and
aboratories will depend on having standardised approaches and
ethodologies. Though such standardisation is not yet in place,
fforts have been begun in this direction (e.g. Jenkins et al., 2004;
iehn et al., 2007) and comprehensive protocols have been pub-
ished (e.g. de Vos et al., 2007; Kim et al., 2010). Its limitations
otwithstanding, NMR  is a suitable method for FP that offers the
equired reproducibility with only few parameters to be agreed on
Verpoorte et al., 2007), and hence would complement the widely
sed but less comparable chromatographic FP for extracts in bioac-
ivity studies. Still, the rational modernisation of CHM requires
oordinated studies on extracts’ chemical proﬁles and pharmaco-
ogical properties identifying the active and auxiliary components
n order to conserve the traditional experience in modernised appli-
ation forms. Current methodologies result in the majority of the
edicine and its various synergisms not being fully represented
n QC practices. It seems realistic to approach the modernisation
f CHM by ﬁrstly providing a solid basis for QC methods that will
eﬂect its special features.
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